Upcoming Courses

27th Annual Summer Seminars: Essential Psychopharmacology 2016: From Neuroscience to Advances in Treatment

Charles Nemeroff, MD, PhD

August 22, 2016 – August 26, 2016 | Edgartown, MA | Harbor View Hotel More Information

This seminar will provide an updated review of recent advances in neurobiology, genetics, and brain imaging with a focus on the pathophysiology of the major psychiatric disorders. Specific categories of treatment will include treatment of schizophrenia, bipolar disorder, depression, anxiety disorders including PTSD and comorbid sleep disorders, and borderline personality. The effectiveness of atypical and conventional antipsychotic drugs as well as newer medications will be reviewed. The seminar will address strategies for bipolar patients who are noncompliant or treatment-resistant; approaches to the acutely psychotic, recovering psychotic patient, and the concept of early intervention. The role of switch versus augmentation, and combination strategies for treatment-resistant depression will be reviewed as well as best treatments for subtypes of major depression including post-partum and atypical depression. This seminar will identify varying psychological approaches for alcohol and substance abuse disorders. It will also address the therapeutic uses of psychotropic drugs across the life cycle of women.

Psychiatric medications for the elderly will be reviewed, including dosage adjustments for age, drug interactions, and sensitivity to side effects. The role of psychopharmacology in the treatment of generalized anxiety disorders, obsessive-compulsive symptoms, panic symptoms, and traumatic syndromes will be highlighted. The course will emphasize the establishment and importance of therapeutic alliance when prescribing all psychotropic medications, the interplay between pharmacologic and non-pharmacologic treatments, benefits and hazards of prescriber/non-prescriber co-treatment relationships. Educational presentation will be in seminar format and include lectures, participant discussion and Q&A.

This course is designed so that participants will be able to:
  • Evaluate psychotropic drug treatment options with particular emphasis on recent advances and practical prescribing information;
  • Explain the latest research in neurobiology, genetics, and brain function;
  • Implement treatment strategies for bipolar patients who are noncompliant or treatment-resistant;
  • Incorporate evidence-based approaches to treating acutely psychotic and recovering psychotic patients;
  • Determine when to implement switch versus combination or augmentation strategies for treatment-resistant depression;
  • Make dosage adjustments in the elderly for age, drug interactions, and sensitivity to side effects;
  • Describe the role of psychopharmacology in the treatment of generalized anxiety disorder, obsessive symptoms, panic symptoms, and traumatic syndromes;
  • Describe the interplay between pharmacologic and non-pharmacologic treatments;
  • Identify the mechanisms and treatment for alcohol and substance abuse disorders;
  • Determine the role of antidepressants in various disorders across the life cycle of women.

Additional Information

Monday, August 22, 2016

8:30-9:00 AM

Registration

9:00-10:15 AM

A simplified and clinically relevant review of neurobiology as it applies to clinical psychopharmacology; neurotransmission, synapses, second messengers; gene function and an introduction to gene/environment interactions and prevention.

10:15-10:30 AM

Continental Coffee Break

10:30-12:15 PM

Review of the importance of childhood maltreatment in increasing risk for psychiatric disorders in adulthood.

Tuesday, August 23, 2016

9:00-10:15 AM

Biology and treatment of schizophrenia: the new generation of antipsychotic drugs.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Clinical aspects of treatment: use of typical and atypical neuroleptics; concept of early intervention and prevention; dual diagnosis; treatment of bipolar disorders including bipolar depression; Q&A.

Wednesday, August 24, 2016

9:00-10:15 AM

Psychopharmacological Management of Depression; Neurobiology of Depression; diagnostic heterogeneity; what constitutes response?

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Value of tricyclics; SSRIs, MAOIs, treatment of drug and alcohol abuse in perspective; new antidepressants; combination and augmentation strategies. Q&A.

Thursday, August 25, 2016

9:00-10:15 AM

Personalized Medicine in Psychiatry: Matching the patient with the optimal treatment.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Anxiety disorders with a focus on PTSD: which drug, when to use; how much and for how long? which psychotherapy? Q&A.

Friday, August 26, 2016

9:00-10:15 AM

Mood disorders in Women: Diagnosis and Treatment.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Psychopharmacology of your most complex patients. Q&A.

12:15 PM

Adjourn

Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15

Accreditation:

Physicians This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of pmiCME and The Continuing Education Program at Beth Israel Deaconess Medical Center. pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION:

Weeklong Seminar: pmiCME designates the live activity for a maximum of 15 AMA PRA Category 1 Credits™
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits(ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Psychologists The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.

Counselors The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5689. Programs that do not qualify for NBCC credit are clearly identified. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is solely responsible for all aspects of the programs.

Social Workers For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: sjruiz@bidmc.harvard.edu.

Nurses Applications have been made for the following programs to the Massachusetts Association of Registered Nurses Inc. an approved provider of nursing credits by the American Nurses Credentialing Center’s Commission on Accreditation

Charles Nemeroff, MD, PhD is Leonard M. Miller Professor and Chairman in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. He is the past President of the American College of Psychiatrists, International Society of Psychoneuroendocrinology and the American College of Neuropsychopharmacology. Dr. Nemeroff is a member of the Institute of Medicine. He is the author of over 1000 scientific articles and book chapters. He is also editor ofManagement of Treatment–Resistant Major Psychiatric Disorders and Co-editorEssentials of Clinical Psychopharmacology and The Bi-polar Book: History, Neurology and Treatment.